Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Cytotherapy|April 21, 2025
CAR T cells re-directed by a rationally designed human peptide tag demonstrate efficacy in preclinical modelsNele Knelangen, Ulrika Bader, Evangelia Maniaki, et al.
Molecular Therapy. Methods & Clinical Development|July 30, 2025
A novel pseudotype derived of the canine distemper virus for adapter-mediated lentiviral transduction <i>in vivo</i>Nora Winter, Carolin Kolbe, Shima Ferdos, et al.
Stem Cells (Dayton, Ohio)|September 2, 2008
The antitumorigenic response of neural precursors depends on subventricular proliferation and ageJoo-Hee Walzlein, Michael Synowitz, Boris Engels, et al.
Molecular Therapy. Oncology|April 11, 2024
CAR'TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatmentKarin Teppert, Isabella Elias Yonezawa Ogusuku, Caroline Brandes, et al.
Blood Neoplasia|January 15, 2026
Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomasJulio C Chavez, Ellen Napier, Attilio Bondanza, et al.
Oncoimmunology|February 1, 2014
Longitudinal confocal microscopy imaging of solid tumor destruction following adoptive T cell transferAndrea Schietinger, Ainhoa Arina, Rebecca B Liu, et al.
Cancer Immunology Research|January 24, 2014
Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancerDavid C Binder, Boris Engels, Ainhoa Arina, et al.
Nature|April 27, 2017
Tumour ischaemia by interferon-γ resembles physiological blood vessel regressionThomas Kammertoens, Christian Friese, Ainhoa Arina, et al.
Immunity|June 23, 2016
Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control AdenocarcinomaAvery D Posey, Robert D Schwab, Alina C Boesteanu, et al.
Pageof 4